FDA Requiring Stronger Safety Labels for Opioid Medications

FDA to Approve New Use of Cancer Drug, Leucovorin for Autism Symptoms in Kids

drugs.com - 23/Sep 14:09

TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...

FDA to Approve New Use of Cancer Drug, Leucovorin for Autism Symptoms in Kids

drugs.com - 23/Sep 14:09

TUESDAY, Sept. 23, 2025 — A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate...

U.S. Officials To Review COVID Vaccine Safety in Pregnancy, Kids

drugs.com - 16/Sep 14:30

TUESDAY, Sept. 16, 2025 — Federal health officials are reviewing safety data on COVID vaccines in pregnant women and children, and may also...

FDA Approves Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) Subcutaneous Injection Formulation of Keytruda for Use in Solid Tumors

drugs.com - 23/Sep 01:09

RAHWAY, N.J.--(BUSINESS WIRE) September 19, 2025 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the...

FDA Approves Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) Subcutaneous Injection Formulation of Keytruda for Use in Solid Tumors

drugs.com - 23/Sep 01:09

RAHWAY, N.J.--(BUSINESS WIRE) September 19, 2025 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the...

Incyte Announces Additional FDA Approval of Opzelura (ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

drugs.com - 18/Sep 06:09

WILMINGTON, Del.--(BUSINESS WIRE)--Sep. 18, 2025-- Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Incyte Announces Additional FDA Approval of Opzelura (ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

drugs.com - 18/Sep 06:09

WILMINGTON, Del.--(BUSINESS WIRE)--Sep. 18, 2025-- Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved...

Trump tells pregnant women 'don't take Tylenol', contradicting standard guidance

wn.com - 22/Sep 23:14

President Trump and top health officials Monday said pregnant women should not take acetaminophen for pain relief due to a potential link to autism....

FDA proposes ban on Orange B, a food dye not used for decades

wn.com - 17/Sep 20:09

Federal regulators are proposing to remove another artificial dye from the U.S. food supply — Orange B, a synthetic color that hasn't been used in...

FDA proposes ban on Orange B, a food dye not used for decades

wn.com - 17/Sep 20:09

Federal regulators are proposing to remove another artificial dye from the U.S. food supply — Orange B, a synthetic color that hasn't been used in...

Rubriques :

FDA Requiring Stronger Safety Labels for Opioid Medications

Articles similaires

FDA to Approve New Use of Cancer Drug, Leucovorin for Autism Symptoms in Kids

FDA to Approve New Use of Cancer Drug, Leucovorin for Autism Symptoms in Kids

U.S. Officials To Review COVID Vaccine Safety in Pregnancy, Kids

FDA Approves Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) Subcutaneous Injection Formulation of Keytruda for Use in Solid Tumors

FDA Approves Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) Subcutaneous Injection Formulation of Keytruda for Use in Solid Tumors

Incyte Announces Additional FDA Approval of Opzelura (ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

Incyte Announces Additional FDA Approval of Opzelura (ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

Trump tells pregnant women 'don't take Tylenol', contradicting standard guidance

FDA proposes ban on Orange B, a food dye not used for decades

FDA proposes ban on Orange B, a food dye not used for decades

Les derniers communiqués